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From its inception in 1997, the ACR/EULAR exchange
program (AEEP) has brought young rheumatologists
together from Europe and the USA. Over 40 junior phy-
sician-scientists and their respective senior rheumatolo-
gist mentors have travelled across the Atlantic Ocean to
meet with and discuss science, medicine, and clinical
practice patterns with their counterparts on the opposite
side of the Pond. The format for the program of attend-
ing either the ACR Annual Scientific Meeting (the Eur-
opean colleagues) or the EULAR meeting (the American
colleagues) followed by visiting several outstanding aca-
demic institutions in the week subsequent to the meet-
ing has remained virtually unchanged since the
beginnings of the AEEP [1]. However, with the current
economic down-turnings, continued financial support
for this program has been threatened. The survival of
the AEEP should be considered in the context of its
intended goals, namely creating a conducive environ-
ment for talented young rheumatology physician-scien-
tists from Europe and America to learn from each other
and form productive scientific collaborations.
One measure of success uniformly utilized in acade-
mia worldwide is quantity and quality of peer-reviewed
scientific publications. To date, over 40 such publica-
tions have resulted from intra-continental collaborations
between AEEP participants [e.g. [2]], and, perhaps more
importantly, 40+ manuscripts have derived from inter-
continental AEEP collaborative efforts [e.g. [3]]. The
scientific topics of these collaborations have varied
widely ranging from interferon-a and lupus [4] to
mouse models of arthritis [5] to cartilage gene therapy
[6] to genome wide association studies [7] to women in
academic rheumatology [8], to textbook chapters [9],
etc. The quality, quantity, and breadth of scope of these
80+ publications alone attests to the remarkable success
of the AEEP in bringing promising junior physician-
scientists from America together with their counterparts
in Europe and vice versa.
Notable spin-offs from the AEEP that have also been
quite successful have been the yearly AEEP Study
Group sessions held at the ACR Annual Scientific Meet-
ings and the corresponding “Forum for Young Rheuma-
tologists” at the EULAR meetings. Because the AEEP
group as a whole has a broad spectrum of research
interests and scientific approaches this has allowed for a
rather varied group of rheumatology related topics in
these special sessions each year. The symposia have
allowed for talks from the AEEP young investigators
alongside lectures from invited experts in the field of
study for the particular topic of that year’sA E E PS t u d y
Group and Forum for Young Rheumatologists’ meeting.
Previous topics and speakers in the recent past have
included the following: “Synoviocyte and NK T Cell Sig-
naling” with Drs. Gary Firestein (University of Califor-
nia, San Diego) and Mitchell Kronenberg (La Jolla
Institute for Allergy & Immunology), “Regulatory T
Cells and Autoimmunity” with Drs. Ethan Shevach
(National Institutes of Health) and Berent Prakken (Uni-
versity Medical Center, Utrecht), “Aging and Autoim-
munity” with Drs. Bruce Richardson (University of
Michigan) and Cornelia Weyand (Emory University),
“Endothelium and Autoimmunity” with Drs. Ulrich von
Andrian (Harvard University) and Umar Mahmood
(Harvard University), and most recently, “Interleukin-1
and Related Molecules” with Drs. Hasan Yacizi (Univer-
sity of Istanbul) and Cem Gabay (University Hospitals of
Geneva), as well as “B Cell Targets in Rheumatology”
with Dr. Peter Lipsky (formerly at the NIH). Whether or
not the AEEP continues on as originally intended (as an
exchange program), it is likely the study group sessions
will continue for the excellence of the content presented
by the junior and more senior lecturers.
If the ACR and EULAR decide to re-establish the
exchange program portion of the AEEP, the success of
the venture will continue to rely heavily on the quality
and enthusiasm of the selected junior faculty physician-
* Correspondence: rcron@peds.uab.edu
1Department of Pediatrics, Division of Rheumatology, University of Alabama
at Birmingham, USA
Full list of author information is available at the end of the article
Cron and Schulze-Koops Pediatric Rheumatology 2011, 9:14
http://www.ped-rheum.com/content/9/1/14
© 2011 Cron and Schulze-Koops; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.scientists, but will also be dependent on outstanding
host faculty and institutions. Some 14 years after its
implementation there have been no less than 16 (Drs.
Aringer, Colbert, Cope, Cron, Diakh, Elewaut, Ferguson,
Huizinga, Muller-Ladner, Oa t e s ,P a p ,S c h u l z e - K o o p s ,
Schanberg, Singer, Voll, and Von Scheven) of its
approximately 40 AEEP “junior” faculty participants who
have proceeded to rheumatology directorships at presti-
gious institutions in the USA and Europe. From the
American side, a disproportionate number of pediatric
rheumatologists (6 out of 15 participants, or 40%) have
benefited from this program, and all have gone to direc-
torships. This degree of academic success may in part
reflect the selection process for participation in the
exchange program but also likely demonstrates the ben-
efits accrued from participation. The exchange program
likely would have benefited from involvement of pedia-
tric rheumatologists from Europe, as well as pediatric
rheumatologists serving as senior faculty participants.
Moreover, most all the former junior faculty AEEP par-
ticipants, both adult and pediatric rheumatologists, have
gone on to highly successful academic careers and have
taken on leadership positions in rheumatology spanning
the Atlantic Ocean as the founders of the AEEP could
only have hoped for when the program was first con-
templated. This seems to have been a rather strong
return on investment for the ACR and the EULAR.
If, on the other hand, the American/European
exchange portion of the AEEP comes to an end, it was
the privilege of all the former participants to have been
involved in this ambitious endeavor. For most all partici-
pants, junior and senior scientists alike, participation in
the AEEP was a stepping stone to further and greater
academic success, a camaraderie of sorts, a source of
many and varied rich scientific collaborations, and, if
nothing else, a conduit to long lasting friendships brid-
ging the Atlantic Ocean.
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